A Retrospective Study of Cemiplimab Effectiveness in Elderly Patients with Squamous Cell Carcinoma of the Skin: Insights from a Real-Life Scenario

A Retrospective Study of Cemiplimab Effectiveness in Elderly Patients with Squamous Cell Carcinoma of the Skin: Insights from a Real-Life Scenario

Abstract Introduction This retrospective study investigates the efficacy of cemiplimab, a monoclonal antibody targeting the PD-1 receptor, in treating squamous cell carcinoma (SCC) of the skin. Methods The study analyzes data from 50 patients with SCC, focusing on various clinical parameters, includ...

Full description

Bibliographic Details
Main Authors: Giuseppe Di Lorenzo, Aieta Michele, Leo Silvana, Domenico Bilancia, Rossella Di Trolio, Michela Rosaria Iuliucci, Concetta Ingenito, Roberta Rubino, Arianna Piscosquito, Michele Caraglia, Marianna Donnarumma, Ferdinando Costabile, Raffaele Conca, Marco Pisino, Angelo Vaia, Luca Scafuri, Antonio Verde, Carlo Buonerba
Format: Article
Language:English
Published: Adis, Springer Healthcare 2023-12-01
Series:Oncology and Therapy
Subjects:
Cemiplimab
Squamous cell carcinoma
Clinical response
Adverse reactions
Distant metastasis
Survival outcomes
Online Access:https://doi.org/10.1007/s40487-023-00256-1

Internet

https://doi.org/10.1007/s40487-023-00256-1

Similar Items